Showing 1 - 5 results of 5 for search 'A. Avigdor', query time: 0.03s
Refine Results
-
1
-
2
P1571: EVALUATION OF THE CLINICAL IMPACT OF BONE MARROW CULTURES IN CURRENT MEDICAL PRACTICE by G. Sharvit, D. Schwartz, G. Heering, A. Shulman, A. Avigdor, G. Rahav, A. Toren, A. Nagler, J. Canaani
Published 2022-06-01
Article -
3
P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA by S. Fried, M. J. Besser, E. Shkury, R. Yerushalmi, N. Shem-Tov, I. Danylesko, E. Jacoby, O. Itzhaki, R. Shouval, M. Kedmi, A. Shimoni, A. Nagler, A. Avigdor
Published 2022-06-01
Article -
4
P1087: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA WHO PROGRESSED AFTER ANTI–PD-1 THERAPY: AN OPEN-LAB... by A. F. Herrera, D. Lavie, N. A. Johnson, A. Avigdor, P. Borchmann, C. Andreadis, A. Bazargan, G. Gregory, C. Keane, T. Inna, V. Vucinic, P. L. Zinzani, H. Zhang, P. Pillai, P. Marinello, J. Timmerman
Published 2022-06-01
Article -
5
P1086: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN ANTI–PD-1–NAIVE PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: AN OPEN-LABEL PHASE 1/2 STUDY... by G. Gregory, J. Timmerman, D. Lavie, P. Borchmann, A. F. Herrera, L. Minuk, V. Vucinic, P. Armand, A. Avigdor, R. Gasiorowski, Y. Herishanu, C. Keane, J. Kuruvilla, J. Palcza, P. Pillai, P. Marinello, N. A. Johnson
Published 2022-06-01
Article